Literature DB >> 30575209

Evidence-based medicine as science.

Joseph Vere1, Barry Gibson2.   

Abstract

Evidence-based medicine has claimed to be science on a number of occasions, but it is not clear that this status is deserved. Within the philosophy of science, four main theories about the nature of science are historically recognized: inductivism, falsificationism, Kuhnian paradigms, and research programmes. If evidence-based medicine is science, knowledge claims should be derived using a process that corresponds to one of these theories. This paper analyses whether this is the case. In the first section, different theories about the nature of science are introduced. In the second section, the claim that evidence-based medicine is science is reinterpreted as the claim that knowledge claims derived from randomized controlled trails and meta-analyses are science. In the third section, the knowledge claims valued within evidence-based medicine are considered from the perspective of inductivism, falsificationism, Kuhnian paradigms, and research programmes. In the final section, possible counter arguments are considered. It is argued that the knowledge claims valued by evidence-based medicine are not justified using inductivism, falsificationism, Kuhnian paradigms, or research programmes. If these are the main criteria for evaluating if something is science or not, evidence-based medicine does not meet these criteria.
© 2018 John Wiley & Sons, Ltd.

Keywords:  Kuhnian paradigm; epistemology; evidence-based medicine; falsificationism; inductivism; research programme

Year:  2018        PMID: 30575209     DOI: 10.1111/jep.13090

Source DB:  PubMed          Journal:  J Eval Clin Pract        ISSN: 1356-1294            Impact factor:   2.431


  2 in total

1.  [No Evidence for the Biomechanical and Pathophysiological Explanatory Models of Musculoskeletal Diseases According to Liebscher & Bracht].

Authors:  Arnold J Suda; Dale Kientopf; Andreas Leithner; Jesko Streeck; Thomas Colshorn; Ronald Dorotka; Markus Schneider; Isabel Höppchen
Journal:  Z Orthop Unfall       Date:  2022-02-10       Impact factor: 0.923

2.  Strength of clinical evidence leading to approval of novel cancer medicines in Europe: A systematic review and data synthesis.

Authors:  Alberto Farina; Federico Moro; Frederick Fasslrinner; Annahita Sedghi; Miluska Bromley; Timo Siepmann
Journal:  Pharmacol Res Perspect       Date:  2021-08
  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.